Determination of anamorelin concentration in human plasma using a simple high-performance liquid chromatography-ultraviolet detection method-Reference-Cited by-同舟云学术

Determination of anamorelin concentration in human plasma using a simple high-performance liquid chromatography-ultraviolet detection method

Published:2024 Issue: Volume: Page:
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Yasu Takeo¹²,Iwatuki Nanami¹,Gando Yoshito¹,Matumoto Yasuhiko³²,Masuo Masahiro⁴,Shirota Mikio⁵,Kobayashi Masayoshi⁴²

Affiliation:

1. Department of Medicinal Therapy Research, Education and Research Unit for Comprehensive Clinical Pharmacy, Meiji Pharmaceutical University, Tokyo, Japan.

2. Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Tokyo, Japan.

3. Department of Microbiology, Meiji Pharmaceutical University, Tokyo, Japan.

4. Department of Respiratory Medicine, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.

5. Department of Pharmacy, Tokyo Metropolitan Toshima Hospital, Tokyo, Japan.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Link

https://www.jstage.jst.go.jp/article/ddt/advpub/0/advpub_2024.01049/_pdf

Reference12 articles.

1. 1. Guillory B, Splenser A, Garcia J. The role of ghrelin in anorexia-cachexia syndromes. Vitam Horm. 2013; 92:61-106.

2. 2. Anker MS, Holcomb R, Muscaritoli M, von Haehling S, Haverkamp W, Jatoi A, Morley JE, Strasser F, Landmesser U, Coats AJS, Anker SD. Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review. J Cachexia Sarcopenia Muscle. 2019; 10:22-34.

3. 3. Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, Fearon KC. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016; 17:519-531.

4. 4. Currow D, Temel JS, Abernethy A, Milanowski J, Friend J, Fearon KC. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia. Ann Oncol. 2017; 28:1949-1956.

5. 5. Zhang H, Garcia JM. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC. Expert Opin Pharmacother. 2015; 16:1245-1253.